Patents for C12R 1 - Micro-organisms (92,025)
09/2003
09/11/2003US20030170233 Treating Autoimmune Diseases with Humanized Anti-CD40L Antibody
09/11/2003US20030170217 Bifidobacterium in the treatment of inflammatory disease
09/10/2003EP1343013A1 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents.
09/10/2003EP1342787A2 Arachidonic acid and methods for the production and use thereof
09/10/2003EP1342785A1 Gene hd3a inducing flowering of plant and utilization thereof
09/10/2003EP1341926A2 Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production
09/10/2003EP1341899A2 Bacterial host strains
09/10/2003EP1341814A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/10/2003EP1341758A2 Coniosetin and derivatives thereof, method for producing the same and use thereof
09/10/2003EP0750682B1 NOVEL PESTICIDAL COMPOSITION AND $i(BACILLUS THURINGIENSIS) STRAIN
09/10/2003EP0736106B1 Methods of screening for beta-amyloid peptide production inhibitors
09/10/2003EP0654092B1 Method for detecting pre-cancerous or cancerous cells using p90 and p53 antibodies or probes
09/10/2003EP0594732B1 Humanized antibody against cd18
09/10/2003CN1441846A Recombinant plasmid PDSBCM, microorganisms transformed therewith, and method for producing alkaline protease VAPK
09/10/2003CN1440992A Molecular weight control method of poly hydroxy alkane acid ester
09/09/2003US6617495 Nucleic acid molecules from plants coding enzymes which participate in the starch synthesis
09/09/2003US6617431 Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses
09/09/2003US6617429 Apoptosis inhibitory protein, gene encoding the protein and cDNA thereof
09/09/2003US6617163 Polynucleotides for mutagenesis in fungus comprising a functional gene in magnaporthe and an impala transposon
09/09/2003US6617159 Serum free medium for chondrocyte cells
09/09/2003US6617145 Enzymatic protein for use in treatment of thrombosis
09/09/2003US6617110 Cultured cell comprising a nucleic acid sequence, encoding the protein, that hybridizes to a polynucleotide of given sequence; use to determine if drug is cytotoxic; can use as anticarcinogenic agent
09/09/2003US6617101 Lipophilic quenching of viral inactivating agents
09/09/2003US6616930 Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method
09/09/2003CA2145630C Microorganisms for the production of tryptophan and process for producing the same
09/04/2003WO2003072786A1 Process for producing l-threonine with the use of bacterium beloniging to the genus escherichia
09/04/2003WO2003072725A2 Recombinant negative strand virus rna expression systems and vaccines
09/04/2003WO2003072601A1 Method for producing hypoallergenic major birch pollen allergens rbet v 1
09/04/2003WO2003071877A1 Compositions and methods for eliciting an immune response to gram-negative bacterial infections
09/04/2003WO2003040379A3 Modulating urea degradation in wine yeast
09/04/2003WO2002101017A3 A mouse unable to express functional alpha-4 integrin protein, and methods for assaying compounds or agents for alpha-4 integrin protein antagonist activity and a genetic marker for evaluating efficacy of modulators of signaling activity of a vla-4 receptor
09/04/2003WO2002083853A3 Method for enhancing the translation and expression of recombinant proteins
09/04/2003WO2002033109A3 Fermentation method for production of heterologous gene products in lactic acid bacteria
09/04/2003US20030167527 Transgenic plant; genetic engineering
09/04/2003US20030167522 Obtained from Bacillus thuringiensis (cry proteins); for activity against corn rootworm pests
09/04/2003US20030167521 Genetic engineered insecticide
09/04/2003US20030167514 For screening/conferring tolerance in plants
09/04/2003US20030166910 Bone morphogenic protein
09/04/2003US20030166895 Gene expression; genetic engineering; central nervous system disorders; cardiovascular disorders; glandular disorders; psychological disorders
09/04/2003US20030166876 Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3
09/04/2003US20030166873 Endothelial growth factor; measuring binding to monoclonal antibodies; calibration
09/04/2003US20030166851 Contacting a polypeptide (Transmembrane serin protease 9) with a substrate that is proteolytically cleaved by the polypeptide, adding a test compound, measuring the amount of substrate cleaved in the presence of test compound
09/04/2003US20030166849 A peptide of at least 5 amino acids containing a unique portion of a semaphorin, and such peptide has a semaphorin binding specificity
09/04/2003US20030166285 Methods and compositions for genetically modifying primate bone marrow cells
09/04/2003US20030166258 Saccharomyces cerevisiae yeast strain with functional expression of a glut transporter
09/04/2003US20030166257 Use of Lactobacillus salivarius
09/04/2003US20030166239 Bone morphogenic proteins; for regulating bone homeostasis, adiposity, and calcification of atherosclerotic plaques
09/04/2003US20030166238 Recombinant toxin fragments
09/04/2003US20030166194 Of given sequence; genetic mapping; anticoagulants
09/04/2003US20030166180 Contacting 3-hydroxynitrile with enzyme catalyst having nitrile hydratase, amidase or nitrilase activity; use in copolyesters
09/04/2003US20030166179 Methods and materials for the synthesis of organic products
09/04/2003US20030166175 Process for clavulanic acid production
09/04/2003US20030166174 Fermenting amino acids using lysine resistant methanobacterium for animal feeds, foodstuffs and drug design
09/04/2003US20030166165 Comprises nucleotide sequences coding polyene macrolide antibiotics for use in veterinary medicine
09/04/2003US20030166116 Nucleotide sequences for the control of the expression of DNA sequences in a cell host
09/04/2003US20030166097 Comprises nucleotide sequences coding membrane proteins for use diagnosing, treating and preventing autoimmune, inflammatory, viral, infectious and cancer diseases
09/04/2003US20030165968 For hydrolysis of nitrile-containing substrates to carboxylic acids; thermostability
09/04/2003US20030165943 Use of compositions consisting of cationic compounds and proton donors for stabilising and/or isolating nucleic acids in or from micro-organisms such as prokaryots, fungi, protozoa or algae
09/04/2003US20030165907 Human glycine transporter type 2
09/04/2003US20030165874 Nucleotide sequences probes for diagnosing and treating seizure disorders; restriction fragment length polymorphisms
09/04/2003US20030165855 Methods for the analysis of non-proteinaceous components using a protease from a bacillus strain
09/04/2003US20030165817 Diagnostic assay
09/04/2003US20030165540 Sentinel virus II
09/04/2003US20030165494 Rheumatic diseases; anticholesterol agents; cardiovascular disorders; multiple sclerosis
09/04/2003US20030165462 Deleted adenovirus vectors and methods of making and administering the same
09/04/2003US20030165459 Binding to tumor necrosis factor
09/04/2003CA2477409A1 Process for the preparation of hypoallergenic major birch pollen allergen rbet v 1
09/04/2003CA2477170A1 Compositions and methods for eliciting an immune response to gram-negative bacterial infections
09/04/2003CA2477037A1 Recombinant negative strand virus rna expression systems and vaccines
09/03/2003EP1340813A1 Process for producing viral rna polymerase
09/03/2003EP1340812A2 Functional domains in flavobacterium okeanokoites (Foki) restriction endonuclease
09/03/2003EP1340811A2 Antibodies with specificity for multiple adhesion molecules
09/03/2003EP1340776A1 Method for controlling molecular weight of polyhydroxyalkanoate constituted of units containing residue of phenyl-, thienyl-, or cyclohexyl-structure in side chain of molecule
09/03/2003EP1339864A2 Process for the production of piperidine derivatives with microorganisms
09/03/2003EP1339852A2 Methods and materials for the synthesis of organic products
09/03/2003EP1339286A2 Bacterial inoculants for enhancing plant growth
09/03/2003EP0828844B1 Promoters for gene expression
09/03/2003EP0739417B1 Production of l-isoleucine by means of recombinant micro-organisms with deregulated threonine dehydratase
09/03/2003EP0711349B1 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis
09/03/2003EP0673425B1 Dna encoding chitin deacetylase
09/03/2003EP0660874B1 Recombinant dnase b derived from streptococcus pyogenes
09/03/2003EP0647273B1 Dna sequences encoding oligosaccharide transporter
09/03/2003EP0607297B1 Hormone analogs with multiple ctp extensions
09/03/2003CN1440461A Process for preparation of dihydroxy esters and derivatives thereof
09/03/2003CN1440460A Microbial production of R-phenylacetylcarbinol by biotransformation of benzaldehyde by filamentous fungi
09/03/2003CN1440456A Sentinel virus Ôàí"
09/03/2003CN1440455A Method for culturing micro-organisms in reducing conditions obtained gas stream
09/03/2003CN1120235C Alkaline protease deficient filamentous fungi
09/02/2003US6613907 Process for the production of piperidine derivatives with microorganisms
09/02/2003US6613891 Polynucleotides that encode bovine inhibin
09/02/2003US6613881 Isolated polypeptide of given amino acid sequence; can use in vaccines
09/02/2003US6613574 Method to identify interface residue in biomolecular complex
09/02/2003US6613559 Simultaneous decolorization and detoxification of molasses spent wash using novel white rot-lignin-modifying fungus Flavodon flavus
09/02/2003US6613557 Recombinant DNA molecules which encode viral protein; transfecting a host cell with the DNA molecules; used for diagnostic purposes or for incorporation in a vaccine
09/02/2003US6613556 Infecting cells from a continuous epithelial or fibroblast cell line, free of contaminants, with a high titer growth strain of dengue virus; use in vaccine production
09/02/2003US6613552 Microbe comprising enzyme-encoding recombinant DNA molecules and a inactivating mutation in at least one DNA molecule which encodes a shikimate kinase isozyme; culturing in presence of a carbon source
09/02/2003US6613550 Microbial process for preparation of optically active 3-hydroxypyrrolidine derivatives
09/02/2003US6613547 Nucleotides; signal sequences; DNA sequences; Saccharomyces; vectors/genetic/; yeasts; proteins; use of recombinant DNA containing transcription sequences in the production of proteins of interest
09/02/2003US6613545 Corynebacterium glutamicum; transport proteins; isoleucine; leucine; valine; nucleotide sequences; replication/genetic/; use to improve production of title amino acids for use in human medicine, pharmaceutical industry and animal nutrition
09/02/2003US6613544 Osteoprotegerin